Next Generation Sequencing Congress
Next Generation Sequencing Congress - 15th & 16th November 2010, Radisson Edwardian, Heathrow, London UK
Next Generation Sequencing Congress is administered by Osney Media.
2 Day Conference
Next Event
Next Generation Sequencing Congress 2010
15th & 16th November
Monday 15th November 2010 to Tuesday 16th November 2010
London, UK, -
£650.00/person

Oxford Global Conference is proud to present the 2nd Annual Next Generation Sequencing (NGS) Congress, which will be held on the 15th & 16th November 2010 in London, UK. The congress is held in conjuction with our 2nd Anua qPCR Congress and our Analytical Genomics Congress

 

Next generation sequencing technologies are revolutioising biology by allowing for genome wide transcription factor binding-site profiling, transcriptome sequencing and more recently, as an endpoint to applications ranging fromchromatin immunoprecipitation, mutation mapping and polymorphism discovery to noncoding RNA discovery.

 

Over the 2 days, the conference provides an overview of the current options of next generation sequencing platform, technologies, applications and the newest computational tools for the analysis of next-generation sequencing data.

 

The three co-located events will attract over 350 senior-level decision makers working in bioinformatics & data management,next generation sequencing, discovery, RNA profiling, molecular genomics and clinical & diagnostics development from the UK, Europe and US. This prestigious event provides a forum for practitioners andresearchers to learn more about key solutions being provided to their industry, network with their peers, andaddress key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment.

 

WHO YOU WILL MEET

 

Delegates are senior practitioners from major pharmaceutical, biotech companies as well as academic institutionsbased in UK and Europe and typically include VPs, Directors and Managers of: Drug Discovery, Next Generation Sequencing,Gene Expression, Epigenetics, Genomics, Sequencing Technology, ChIP Seq, Microarrays, High Throughput Technologies,Molecular Profiling/Diagnostics, Clinical Development, qPCR, Copy Number Variation, Principal Investigation,Bioinformatics, Data Management / Analysis, Biostatistics, Informatics, Semantics / Cloud Computing

 

Programme

 

Next Generation Sequencing Technologies and Data Management
·  High Throughput Sequencing Platforms: Implementation and Technology Considerations

·  Next Generation Sequencing Technologies and Bioinformatics Analysis Tools

·  NGS for Metagenomics

·  Data Analysis, Data Management, LIMS, Storage Strategies
·  Cloud Computing / Semantic web


Next Generation Sequencing Applications
·  
Sequencing Applications Considerations 
·  Applying Next-Generation Sequencing to Cancer, Medical Genetics and Discovery Research
·  Epigenetics / DNA methylation 
·  Personalised Medicine
·  Future perspectives

Hear insights and views from our leading line up of industry experts:
Jurg Bahler Professor of Cellular Systems Biology University College London
Yu Hui Rogers Vice President, Core Technology Development and Services J.Craig Venter Institute
David Dow, Group Leader, Molecular and Cellular Technologies, GlaxoSmithKline
Andrew Feber, Medical Genomics, UCL Cancer Institute, University College London
Juergan Kleffe, Institute for Molecular Biology and Bioinformatics, Berlin, Charite
Kalim Mir, Wellcome Trust Fellow, Principle Investigator, The Wellcome Trust Centre for Human Genetics, University of Oxford
Julian Parkhill, Director of Sequencing, Sanger Institute
Gordon Brown Post-Doctoral Researcher Cancer Research UK Cambridge Research Institute
Neil Gibson, Principal Scientist, Research and Development Genetics, AstraZeneca
John Whittaker Director, Statistical Genetics GSK
Peter Verhasselt Principal Scientist, Translational Genomics & Genetics Johnson & Johnson Pharmaceutical Research & Development
Arjen Brinkman Department of Molecular Biology Nijmegen centre for Molecular Life Sciences
Marc Peeters Department of Oncology University of Oxford
Edward J. Oakeley Biomarker Development - Human Genetics and Genomics - Genome Technologies - Genome Sequencing Lab Novartis Institute for BioMedical Research
Matthew Hall UK Team Leader, Computational Biology GSK
Bhupinder Bhullar Lab Head, Development & Molecular Pathways Novartis
Hendrik Marks, Post Doctural Research, Radbound University
Richard Meehan Human Genetics Unit, Western General Hospital
Bram Herman Agilent Technologies
Mattias Prucha Partek
Robert Nutter Life Technologies
Mario Caccamo The Genome Analysis Centre
Wigard Kloosterman University Medical Center Utrecht, Dept of Medical Genetics
Klaas Zuideveld Roche NimbleGen, Inc
Darrell Dinwiddie Post Doctoral Research Scientist National Centre for Genome Resources
Katja Kobow Institute of Neuropathology
Ryan Jacob DNASTAR
Maria Moreno-Villanueva University of Konstanz
Kristina Warton Ovaarian Cancer Group, Gavan
Fatemeh G Haghighi New York State Psychiatric Institute
Steve Laval Newcastle University
Tomas Babak Senior Research Scientist, Molecular Profiling and Research Informatics Merck Inc
Frederic Raymond Microarray Facility Manager Nestle Research Center, Switzerland
Elaine Sanij Peter MacCallum Cancer Centre
Home |  | About the 3 events |  | 2 Day Conference |  | Colocated qPCR | Event Format | Speakers | Delegates | Sponsors | Testimonials | Media Partners | Submit a Poster | Press Centre | Venue | Organisers | Other Events | Contact | 
© Next Generation Sequencing Congress